|
US4349552A
(en)
|
1978-10-30 |
1982-09-14 |
Fujisawa Pharmaceutical Company, Ltd. |
5-Fluorouracil derivatives, and their pharmaceutical compositions
|
|
NZ221717A
(en)
|
1986-09-10 |
1990-08-28 |
Sandoz Ltd |
Azaindole and indolizine derivatives and pharmaceutical compositions
|
|
WO1990007926A1
(en)
|
1989-01-20 |
1990-07-26 |
Pfizer Inc. |
3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines
|
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
|
FR2687402B1
(fr)
|
1992-02-14 |
1995-06-30 |
Lipha |
Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
|
|
DE4304455A1
(de)
|
1993-02-15 |
1994-08-18 |
Bayer Ag |
Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
|
|
US5994341A
(en)
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
|
IL129871A
(en)
*
|
1994-05-06 |
2003-11-23 |
Pharmacia & Upjohn Inc |
Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
|
|
WO1995033748A1
(en)
|
1994-06-09 |
1995-12-14 |
Smithkline Beecham Corporation |
Endothelin receptor antagonists
|
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
GB9721437D0
(en)
|
1997-10-10 |
1997-12-10 |
Glaxo Group Ltd |
Heteroaromatic compounds and their use in medicine
|
|
US6313126B1
(en)
|
1999-01-07 |
2001-11-06 |
American Home Products Corp |
Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
|
|
JP2002534411A
(ja)
|
1999-01-07 |
2002-10-15 |
ワイス |
鬱病の処置のためのアリールピペラジニル−シクロヘキシルインドール誘導体
|
|
AU2494300A
(en)
|
1999-01-07 |
2000-07-24 |
American Home Products Corporation |
3,4-dihydro-2h-benzo(1,4)oxazine derivatives
|
|
US6265403B1
(en)
|
1999-01-20 |
2001-07-24 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
|
AR028475A1
(es)
|
1999-04-22 |
2003-05-14 |
Wyeth Corp |
Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion.
|
|
US20030153560A1
(en)
|
1999-04-23 |
2003-08-14 |
Salituro Francesco G. |
Inhibitors of c-Jun N-terminal kinases (JNK)
|
|
EP1196167B1
(en)
|
1999-07-02 |
2006-04-19 |
Stuart A. Lipton |
Use of p38 MAPK inhibitors in the treatment of ophthalmic conditions
|
|
GB9919843D0
(en)
|
1999-08-20 |
1999-10-27 |
Smithkline Beecham Plc |
Novel compounds
|
|
DE19948417A1
(de)
|
1999-10-07 |
2001-04-19 |
Morphochem Ag |
Imidazol-Derivate und ihre Verwendung als Arzneimittel
|
|
DE60043397D1
(de)
|
1999-12-28 |
2010-01-07 |
Pharmacopeia Inc |
Cytokine, insbesondere tnf-alpha, hemmer
|
|
US20020065270A1
(en)
|
1999-12-28 |
2002-05-30 |
Moriarty Kevin Joseph |
N-heterocyclic inhibitors of TNF-alpha expression
|
|
AU2001237041B9
(en)
|
2000-02-17 |
2005-07-28 |
Amgen Inc. |
Kinase inhibitors
|
|
US7041277B2
(en)
|
2000-03-10 |
2006-05-09 |
Cadbury Adams Usa Llc |
Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
|
|
CA2308994A1
(en)
|
2000-05-19 |
2001-11-19 |
Aegera Therapeutics Inc. |
Neuroprotective compounds
|
|
ES2262674T3
(es)
|
2000-08-14 |
2006-12-01 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pirazoles sustituidos.
|
|
EP1315741A2
(en)
|
2000-09-06 |
2003-06-04 |
Ortho-McNeil Pharmaceutical, Inc. |
A method for treating allergies
|
|
AU8873101A
(en)
|
2000-09-06 |
2002-03-22 |
Ortho Mcneil Pharm Inc |
A method for treating allergies using substituted pyrazoles
|
|
AR031130A1
(es)
|
2000-09-20 |
2003-09-10 |
Abbott Lab |
N-acilsulfonamidas promotoras de la apoptosis
|
|
WO2002051837A2
(en)
|
2000-12-22 |
2002-07-04 |
Wyeth |
Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
|
|
CA2439263C
(en)
|
2001-03-02 |
2012-10-23 |
Frank Becker |
Three hybrid assay system
|
|
SI1392697T1
(en)
|
2001-03-14 |
2005-02-28 |
Wyeth |
Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino 2,3-f)quinoline
|
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
|
WO2002085896A1
(en)
|
2001-04-24 |
2002-10-31 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
|
|
US6656950B2
(en)
|
2001-04-25 |
2003-12-02 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
|
|
US6593350B2
(en)
|
2001-04-26 |
2003-07-15 |
Wyeth |
Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7H-[1,4]dioxino[2,3-e]indole
|
|
US6656947B2
(en)
|
2001-04-26 |
2003-12-02 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
|
|
BR0209343A
(pt)
|
2001-04-26 |
2004-06-15 |
Wyeth Corp |
Antidepressivos de azaheterociclilmetila derivados de [1,4]-benzodioxanos oxaheterociclo-fundidos; métodos de tratamento usando tais compostos; processo para prepará-los
|
|
MXPA03009826A
(es)
|
2001-04-26 |
2005-03-07 |
Wyeth Corp |
Azaheterociclilmetil derivados de 2,3-dihidro-1,4-dioxino[2,3-f]quinoxalina como agentes antidepresivos.
|
|
WO2002088131A1
(en)
|
2001-04-26 |
2002-11-07 |
Wyeth |
Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta[a]naphthalene
|
|
ES2225798T3
(es)
|
2001-04-30 |
2005-03-16 |
Wyeth |
Derivadis azagetericuckuknetuk de 7,8-dihidro-1,6,9-trioxa-e-aza-ciclopenta(a)naftaleno como antidepresivos.
|
|
US6555560B2
(en)
|
2001-04-30 |
2003-04-29 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
|
|
GB0111186D0
(en)
|
2001-05-08 |
2001-06-27 |
Smithkline Beecham Plc |
Novel compounds
|
|
BR0209901A
(pt)
|
2001-05-17 |
2004-07-13 |
Wyeth Corp |
Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
|
|
EP1399440B1
(en)
|
2001-06-15 |
2009-06-03 |
Vertex Pharmaceuticals Incorporated |
5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors
|
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
US6903110B2
(en)
|
2001-07-25 |
2005-06-07 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
|
|
CA2456292A1
(en)
|
2001-08-14 |
2003-02-27 |
Toyama Chemical Co., Ltd. |
Novel virus growth inhibitor and/or virucidal method, and novel pyrazine nucleotide or pirazine nucleoside analog
|
|
US20040236110A1
(en)
|
2001-09-26 |
2004-11-25 |
Ladouceur Gaetan H |
Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
|
|
US6667322B2
(en)
|
2001-10-05 |
2003-12-23 |
Wyeth |
Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole
|
|
US7361671B2
(en)
|
2001-11-15 |
2008-04-22 |
The Institute For Pharmaceutical Discovery, Inc. |
Substituted heteroarylalkanoic acids
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
AU2003216660A1
(en)
|
2002-04-26 |
2003-11-10 |
Pfizer Products Inc. |
N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
|
|
WO2003091246A1
(en)
|
2002-04-26 |
2003-11-06 |
Vertex Pharmaceuticals Incorporated |
Pyrrole derivatives as inhibitors of erk2 and uses thereof
|
|
TW200406385A
(en)
|
2002-05-31 |
2004-05-01 |
Eisai Co Ltd |
Pyrazole compound and pharmaceutical composition containing the same
|
|
UA78999C2
(en)
|
2002-06-04 |
2007-05-10 |
Wyeth Corp |
1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
|
|
PL374967A1
(en)
|
2002-08-02 |
2005-11-14 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of gsk-3
|
|
WO2004014912A1
(en)
|
2002-08-08 |
2004-02-19 |
Ribapharm Inc. |
Improved synthesis for hydroxyalkylated heterocyclic bases
|
|
SE0202463D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
Novel compounds
|
|
WO2004037814A1
(en)
|
2002-10-25 |
2004-05-06 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
|
KR100983462B1
(ko)
|
2003-02-26 |
2010-09-27 |
베링거 잉겔하임 파르마 게엠베하 운트 코 카게 |
디하이드로프테리디논, 이의 제조방법 및 약제로서의 이의 용도
|
|
EP1599475A2
(en)
|
2003-03-06 |
2005-11-30 |
Eisai Co., Ltd. |
Jnk inhibitors
|
|
CA2518318A1
(en)
|
2003-03-17 |
2004-09-30 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
GB0308466D0
(en)
|
2003-04-11 |
2003-05-21 |
Novartis Ag |
Organic compounds
|
|
WO2005000813A1
(en)
|
2003-05-30 |
2005-01-06 |
Imclone Systems Incorporated |
Heteroarylamino-phenylketone derivatives and their use as kinase inhibitors
|
|
WO2004106298A1
(en)
|
2003-05-30 |
2004-12-09 |
Janssen Pharmaceutica N.V. |
Indole derivatives with an improved antipsychotic activity
|
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
|
WO2005044181A2
(en)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
|
|
EP1675830A4
(en)
|
2003-09-30 |
2008-08-20 |
Scios Inc |
HETEROCYCLIC AMIDES AND SULFONAMIDES
|
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
|
US20070066641A1
(en)
|
2003-12-19 |
2007-03-22 |
Prabha Ibrahim |
Compounds and methods for development of RET modulators
|
|
DK1696920T3
(en)
|
2003-12-19 |
2015-01-19 |
Plexxikon Inc |
RELATIONS AND PROCEDURES FOR THE DEVELOPMENT OF LAW MODULATORS
|
|
GB0405055D0
(en)
|
2004-03-05 |
2004-04-07 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
|
WO2005095400A1
(en)
|
2004-03-30 |
2005-10-13 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of jak and other protein kinases
|
|
MXPA06011328A
(es)
|
2004-04-02 |
2006-12-15 |
Vertex Pharma |
Azaindoles utiles como inhibidotes de roca y otras proteinas cinasas.
|
|
ITMI20040874A1
(it)
|
2004-04-30 |
2004-07-30 |
Ist Naz Stud Cura Dei Tumori |
Derivati indolici ed azaindolici con azione antitumorale
|
|
KR100476851B1
(ko)
|
2004-05-18 |
2005-03-17 |
(주)성신엔지니어링 |
중력식 섬유여과기
|
|
WO2006009797A1
(en)
|
2004-06-17 |
2006-01-26 |
Plexxikon, Inc. |
Azaindoles modulating c-kit activity and uses therefor
|
|
DE102004029784A1
(de)
|
2004-06-21 |
2006-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
|
|
US20050288290A1
(en)
|
2004-06-28 |
2005-12-29 |
Borzilleri Robert M |
Fused heterocyclic kinase inhibitors
|
|
US20060122213A1
(en)
|
2004-06-30 |
2006-06-08 |
Francoise Pierard |
Azaindoles useful as inhibitors of protein kinases
|
|
JP2008508303A
(ja)
|
2004-07-27 |
2008-03-21 |
エスジーエックス ファーマシューティカルズ、インコーポレイテッド |
ピロロ−ピリジンキナーゼモジュレーター
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
CN101068815B
(zh)
|
2004-10-04 |
2012-09-05 |
千禧药品公司 |
有效作为蛋白激酶抑制剂的内酰胺化合物
|
|
WO2006038001A1
(en)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Aminopyrimidine derivatives as jnk inhibitors
|
|
WO2006050076A1
(en)
|
2004-10-29 |
2006-05-11 |
Janssen Pharmaceutica, N.V. |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
|
US7528138B2
(en)
|
2004-11-04 |
2009-05-05 |
Vertex Pharmaceuticals Incorporated |
Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
|
|
NZ555566A
(en)
|
2004-11-22 |
2009-12-24 |
Vertex Pharma |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
|
EP1828180A4
(en)
|
2004-12-08 |
2010-09-15 |
Glaxosmithkline Llc |
1H-pyrrolo [2,3-BETA] PYRIDINE
|
|
US8101770B2
(en)
|
2004-12-16 |
2012-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyridones useful as inhibitors of kinases
|
|
US20060161001A1
(en)
|
2004-12-20 |
2006-07-20 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
JP5227032B2
(ja)
|
2005-02-03 |
2013-07-03 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼの阻害剤として有用なピロロピリミジン
|
|
PL1896470T3
(pl)
|
2005-05-16 |
2011-03-31 |
Irm Llc |
Pochodne pirolopirydynowe jako inhibitory kinazy białkowej
|
|
RU2435769C2
(ru)
|
2005-05-20 |
2011-12-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Пирролопиридины, полезные в качестве ингибиторов протеинкиназы
|
|
WO2007002433A1
(en)
*
|
2005-06-22 |
2007-01-04 |
Plexxikon, Inc. |
Pyrrolo [2, 3-b] pyridine derivatives as protein kinase inhibitors
|
|
GB0516156D0
(en)
|
2005-08-05 |
2005-09-14 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
|
NZ567133A
(en)
|
2005-09-30 |
2011-07-29 |
Vertex Pharma |
Deazapurines useful as inhibitors of janus kinases
|
|
US8017781B2
(en)
|
2005-11-15 |
2011-09-13 |
Vertex Pharmaceuticals Incorporated |
Azaindazoles useful as inhibitors of kinases
|
|
US20130096302A1
(en)
|
2005-11-22 |
2013-04-18 |
Hayley Binch |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
|
NZ601687A
(en)
|
2006-01-17 |
2014-03-28 |
Vertex Pharma |
Azaindoles useful as inhibitors of janus kinases
|
|
JP2009528991A
(ja)
|
2006-02-14 |
2009-08-13 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼの阻害剤として有用なピロロ（３，２−ｃ）ピリジン
|
|
DE602007008837D1
(de)
|
2006-02-14 |
2010-10-14 |
Vertex Pharma |
Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
|
|
DE102006012617A1
(de)
|
2006-03-20 |
2007-09-27 |
Merck Patent Gmbh |
4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
|
|
US8741912B2
(en)
|
2006-04-05 |
2014-06-03 |
Vertex Pharmaceuticals Incorporated |
Deazapurines useful as inhibitors of Janus kinases
|
|
AU2007242594A1
(en)
|
2006-04-26 |
2007-11-01 |
F. Hoffmann-La Roche Ag |
Pyrimidine derivatives as PI3K inhibitors
|
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
|
US20090017444A1
(en)
|
2006-06-09 |
2009-01-15 |
Wisconsin Alumni Research Foundation |
Screening method for modulators of viral transcription or replication
|
|
JP5642963B2
(ja)
|
2006-06-30 |
2014-12-17 |
スネシス ファーマシューティカルズ，インコーポレイティド |
ピリジノニルｐｄｋ１阻害剤
|
|
TW200808325A
(en)
|
2006-07-06 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds
|
|
WO2008018426A1
(en)
|
2006-08-08 |
2008-02-14 |
Chugai Seiyaku Kabushiki Kaisha |
Pyrimidine derivative as pi3k inhibitor and use thereof
|
|
CA2660758A1
(en)
|
2006-08-24 |
2008-02-27 |
Astrazeneca Ab |
Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
|
|
US20130310418A1
(en)
|
2006-11-15 |
2013-11-21 |
Vertex Pharmaceuticals Incorporated |
Azaindazoles useful as inhibitors of kinases
|
|
CA2672612A1
(en)
|
2006-12-14 |
2008-06-26 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as protein kinase inhibitors
|
|
CN101678022A
(zh)
|
2006-12-21 |
2010-03-24 |
弗特克斯药品有限公司 |
可用作蛋白激酶抑制剂的5-氰基-4-(吡咯并[2,3b]吡啶-3-基)嘧啶衍生物
|
|
TW200840581A
(en)
|
2007-02-28 |
2008-10-16 |
Astrazeneca Ab |
Novel pyrimidine derivatives
|
|
JP2010520887A
(ja)
|
2007-03-09 |
2010-06-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
蛋白キナーゼの阻害剤として有用なアミノピリジン
|
|
MX2009009590A
(es)
|
2007-03-09 |
2009-11-10 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de proteinas cinasas.
|
|
JP5393489B2
(ja)
|
2007-03-09 |
2014-01-22 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
蛋白キナーゼの阻害剤として有用なアミノピリミジン
|
|
JP5087640B2
(ja)
|
2007-03-22 |
2012-12-05 |
武田薬品工業株式会社 |
Ｐｌｋ１阻害剤として有用な置換ピリミドジアゼピン
|
|
RU2339637C1
(ru)
|
2007-04-05 |
2008-11-27 |
Андрей Александрович Иващенко |
Блокаторы гистаминного рецептора для фармацевтических композиций, обладающих противоаллергическим и аутоиммунным действием
|
|
AU2008236872B2
(en)
|
2007-04-05 |
2013-01-17 |
Alla Chem, Llc |
Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and use thereof
|
|
CN101790532B
(zh)
|
2007-07-31 |
2013-11-20 |
沃泰克斯药物股份有限公司 |
5-氟-1H-吡唑并[3，4-b]吡啶-3-胺及其衍生物的制备方法
|
|
CA2695753A1
(en)
|
2007-08-15 |
2009-02-19 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as protein kinases inhibitors
|
|
CN101878216B
(zh)
|
2007-09-28 |
2013-07-10 |
西克拉塞尔有限公司 |
作为蛋白激酶抑制剂的嘧啶衍生物
|
|
SG185289A1
(en)
|
2007-10-09 |
2012-11-29 |
European Molecular Biology Lab Embl |
Soluble fragments of influenza virus pb2 protein capable of binding rna-cap
|
|
EP2215089B1
(en)
|
2007-11-02 |
2012-06-27 |
Vertex Pharmaceuticals Incorporated |
[1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
|
|
DK2207775T3
(da)
|
2007-11-05 |
2012-06-18 |
Novartis Ag |
4-Benzylamino-1-carboxyacylpiperidinderivater som CETP-inhibitorer, som er anvendelige til behandling af sygdomme som hyperlipidæmi eller arteriosclerose
|
|
CN101939324B
(zh)
|
2008-02-25 |
2014-10-15 |
霍夫曼-拉罗奇有限公司 |
吡咯并吡嗪激酶抑制剂
|
|
EP2262498A2
(en)
|
2008-03-10 |
2010-12-22 |
Vertex Pharmceuticals Incorporated |
Pyrimidines and pyridines useful as inhibitors of protein kinases
|
|
WO2009125395A1
(en)
|
2008-04-09 |
2009-10-15 |
Technion Research & Development Foundation Ltd. |
Anti influenza antibodies and uses thereof
|
|
KR20110039278A
(ko)
|
2008-06-23 |
2011-04-15 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나제 억제제
|
|
CN102076691A
(zh)
|
2008-06-23 |
2011-05-25 |
维泰克斯制药公司 |
蛋白激酶抑制剂
|
|
US8569337B2
(en)
|
2008-07-23 |
2013-10-29 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
|
WO2010011768A1
(en)
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
|
JP2011529066A
(ja)
|
2008-07-23 |
2011-12-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
三環式ピラゾロピリジンキナーゼ阻害剤
|
|
WO2010011756A1
(en)
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridine kinase inhibitors
|
|
WO2010011762A1
(en)
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridine kinase inhibitors
|
|
EP2427464A1
(en)
|
2009-05-06 |
2012-03-14 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridines
|
|
AU2010262905B2
(en)
|
2009-06-17 |
2015-04-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
WO2011000566A2
(en)
|
2009-06-30 |
2011-01-06 |
Savira Pharmaceuticals Gmbh |
Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
|
|
JP2012533553A
(ja)
|
2009-07-15 |
2012-12-27 |
アボット・ラボラトリーズ |
ピロロピリジン系キナーゼ阻害薬
|
|
JP5685895B2
(ja)
*
|
2009-12-11 |
2015-03-18 |
株式会社リコー |
画像処理装置、画像処理方法およびプログラム
|
|
AR081069A1
(es)
|
2010-04-07 |
2012-06-06 |
Vertex Pharma |
Formas solidas del acido 3-(6-(1-(2,2-difluorbenzo[d][1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benzoico
|
|
NZ603446A
(en)
|
2010-04-14 |
2014-05-30 |
Array Biopharma Inc |
5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of jak kinases
|
|
US20130040933A1
(en)
|
2010-04-27 |
2013-02-14 |
Brandon Cash |
Azaindoles as janus kinase inhibitors
|
|
AU2011343646A1
(en)
|
2010-12-16 |
2013-05-02 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
MX2013006840A
(es)
|
2010-12-16 |
2014-01-31 |
Vertex Pharma |
Inhibidores de la replicacion de los virus de la influenza.
|
|
KR20140014110A
(ko)
|
2010-12-16 |
2014-02-05 |
버텍스 파마슈티칼스 인코포레이티드 |
인플루엔자 바이러스 복제의 억제제
|
|
WO2013006634A2
(en)
|
2011-07-05 |
2013-01-10 |
Vertex Pharmaceuticals Incorporated |
Processes and intermediates for producing azaindoles
|
|
UA118010C2
(uk)
*
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
|
JP2014532765A
(ja)
|
2011-11-07 |
2014-12-08 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
炎症性疾患を処置する方法およびそのために有用な薬学的組み合わせ物
|
|
EP2858984A1
(en)
|
2012-06-08 |
2015-04-15 |
Vertex Pharmaceuticals Inc. |
Inhibitors of influenza viruses replication
|
|
JP6448647B2
(ja)
|
2013-09-12 |
2019-01-09 |
アリオス バイオファーマ インク． |
アザ−ピリドン化合物およびその用途
|
|
US9296727B2
(en)
|
2013-10-07 |
2016-03-29 |
Vertex Pharmaceuticals Incorporated |
Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
|
|
ES2741444T3
(es)
|
2013-11-13 |
2020-02-11 |
Vertex Pharma |
Inhibidores de la replicación de virus de la gripe
|
|
EP3068782B1
(en)
|
2013-11-13 |
2018-05-23 |
Vertex Pharmaceuticals Incorporated |
Methods of preparing inhibitors of influenza viruses replication
|
|
CA2930105A1
(en)
|
2013-11-13 |
2015-05-21 |
Vertex Pharmaceuticals Incorporated |
Formulations of azaindole compounds
|
|
UA124609C2
(uk)
|
2014-08-08 |
2021-10-20 |
Янссен Саєнсиз Айрленд Юсі |
Індоли для застосування при інфекції, спричиненій вірусом грипу
|
|
EA201790571A1
(ru)
|
2014-09-08 |
2017-08-31 |
Янссен Сайенсиз Айрлэнд Юси |
Пирролопиримидины для применения при инфекции, вызванной вирусом гриппа
|
|
MA40773A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus influenza a
|
|
MA40772A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus de la grippe a
|
|
WO2016183116A1
(en)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Methods of preparing inhibitors of influenza viruses replication
|
|
WO2016183120A1
(en)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
JP6903658B2
(ja)
|
2015-11-27 |
2021-07-14 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
インフルエンザウィルス感染に使用するための複素環インドール
|
|
JP7001601B2
(ja)
|
2016-01-07 |
2022-01-19 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
インフルエンザウイルス感染に使用するための官能化ペンタン酸
|
|
JP6989509B2
(ja)
|
2016-01-20 |
2022-01-05 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
インフルエンザウイルス感染における使用のためのアリール置換ピリミジン
|
|
WO2017223231A1
(en)
|
2016-06-21 |
2017-12-28 |
Alios Biopharma, Inc. |
(s)-8-(benzhydryl )-6-isopropyl-3,5-dioxo- 5, 6,7,8,-tetrahydro-3h-pyrazino-[1,2-b]pyridazin-yl-isobutyrate antiviral agent for use in treating influenza
|
|
EP3609502A1
(en)
|
2017-04-12 |
2020-02-19 |
Vertex Pharmaceuticals Incorporated |
Combination therapies for treating influenza virus infection
|